Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Targeting Adolescent Insomnia to Lessen Overall Risk of Suicidal Behavior

NCT05390918 is registered in ClinicalTrials.gov with Jeff Bridge as lead sponsor.

NCT NCT05390918
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT05390918 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Targeting Adolescent Insomnia to Lessen Overall Risk of Suicidal Behavior
Lead sponsor
Jeff Bridge
Phase
Not applicable
Overall status
Recruiting
Start date
October 20, 2022
Completion date
February 28, 2027
Enrollment
235 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

insomnia, suicidal ideation, suicide, attempted